Stealth Biotherapeutics

our mission: stealth biotherapeutics is an innovative biopharmaceutical company committed to bringing patients mitochondria-targeted therapies to treat both rare and common diseases. driven by a desire to help patients with unmet treatment needs, our team collaborates with well-recognized institutions, physicians and scientists to develop the next generation of therapies focusing on mitochondrial dysfunction in many diseases. we do this by continuing to expand our broad knowledge of mitochondrial biology and novel chemistry, and advancing our mitochondrial platform of late-stage clinical programs and pipeline candidates. our strategy: stealth’s commitment to science and our focus on mitochondria—the cell’s energy source—offer a promising, yet untapped, approach to address many serious, debilitating diseases. these diseases each have significant unmet treatment needs with mitochondrial dysfunction as a common underlying element. our clinical development program is led by elamipretide, a